Orca Bio's manufacturing facility in Sacramento, California. Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to prevent graft-versus ...

Viridian Therapeutics (VRDN) on Saturday launched its first commercial product, Lumvoa, soon after the U.S. FDA approved the intravenous therapy for thyroid eye disease, a rare autoimmune disease ...

ANN ARBOR, Mich., June 15, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today ...

(MENAFN- GlobeNewsWire - Nasdaq) Company's Founder Details Production Growth, Industry Transformation Strategy, and Expanding Commercial Opportunities for Recombinant Spider Silk ANN ARBOR, Mich., ...

Historically, commercial health plans have applied utilization management (UM) less frequently to oncology treatments than to drugs in other therapeutic areas although this may be changing. We ...

Tonix Pharmaceuticals (TNXP) added ~6% in the premarket on Wednesday after announcing an agreement with a group purchasing organization to secure commercial payer coverage for Tonmya, its non-opioid ...

Medical center chain Quantum Physical Therapy & Chiropractic Care has decided to take a crack at Procida Companies’ 589 Christopher Avenue in Brownsville, Brooklyn, Commercial Observer has learned.

Neurogene is looking to make the leap from a clinical biotech to a commercial biopharma with its lead gene therapy and has hired an industry veteran to take the reins. Christy Shafer becomes the ...

PITTSBURGH, PA, UNITED STATES, April 1, 2026 /EINPresswire.com/ — Recover Red, a U.S.-based provider of red light therapy solutions, today announced its expanded ...

Denver, Colorado (www.247marketnews.com)- A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider silk, a material long sought by ...

DENVER, CO, March 18, 2026 (EZ Newswire) -- Kraig Biocraft Laboratories (OTCQB: KBLB) announced that it has deployed one million genetically engineered silkworm eggs across multiple production ...